DNA vaccines for malaria: The past, the present, and the future

Indian Journal of Medical Research

Volumn 106, Issue AUG., 1997, Pages 109-119

  Doolan, Denise L ^a   Hedstrom, Richard C ^a   Wang, Ruobing ^a   Sedegah, Martha ^a   Scheller, Libia F ^a   Hobart, Peter ^a   Norman, Jon A ^a   Hoffman, Stephen L ^a  

^a NAVAL MEDICAL RESEARCH INSTITUTE   (United States)

Author keywords

DNA vaccine; Malaria; Plasmodium; Protective immunity

Indexed keywords

CD8 ANTIGEN; DNA VACCINE; MALARIA VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; IMMUNIZATION; LIVER CELL; MALARIA; MALARIA FALCIPARUM; MOUSE; NONHUMAN; PLASMODIUM FALCIPARUM; PRIMATE; REVIEW; T LYMPHOCYTE;

ANIMALS; FORECASTING; HUMANS; MALARIA VACCINES; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; VACCINES, DNA;

EID: 0030850436     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (77)

1. World Health Organization, Fact Sheet No. 94. 1996 WHO Press Office.
2. Nussenzweig RS, Vanderberg, J, Most H, Orton C. Specificity of protective immunity produced by X-irradialcd Plasmodium berghei sporozoites. Nature 1969; 222 : 488-9.
3. Gwadz RW, Cochrane AH, Nussenzweig, V, Nussenzweig RS. Preliminary studies on vaccination of rhesus monkeys with irradiated sporozoites of Plasmodium knowlesi and characterization of surface antigens of these parasites. Bull WHO 1979; 57: 165-73.
4. Clyde DF, McCarthy VC, Miller RM, Hornick RB. Specificity of protection of man immunized against sporozoite-induced falciparum malaria. Am J Med Sci 1973; 266 : 398-401.
5. Clyde DF, Most H, McCarthy VC, Vanderberg JP. Immunization of man against sporozoite-induced falciparum malaria. Am J Med Sci 1973; 266 : 169-77.
6. Clyde DF, McCarthy VC, Miller RM, Woodward WE. Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites. Am J Trop Med Hyg 1975; 24 : 397-401.
7. Rieckmann K H, Carson P E, Beaudoin RL, Cassells J S, Sell K W. Sporozoite induced immunity in man against an Ethiopian strain of Plasmodium falciparum. Trans R Soc Trop Med Hyg 1974; 68 : 258-9.
8. Rieckmann KH, Beaudoin RL, Cassells JS Sell DW. Use of attenuated sporozoites in the immunization of human volunteers against falciparum malaria. Bull WHO 1979; 57 : 261-5.
9. Herrington DA, Nardin EH, Losonsky G. Bathurst IC, Barr PJ. Hollingdale MR, et al. Safety and immunogenicity of a recombinant sporozoite malaria vaccine against Plasmodium vivax. Am J Trop Med Hyg 1991; 45 : 695-701.
10. Egan JE, Hoffman SL, Haynes JD, Sadoff JC, Schneider I. Grau GE et al. Humoral immune response in volunteers immunized with irradiated Plasmodium falciparum sporozoites. Am J Trop Med Hyg 1993; 49 : 166-73.
11. Edelman R, Hoffman SL, Davis JR, Beier M, Sztein MB, Losonsky G et al. Long-term persistence of sterile immunity in a volunteer immunized with X-irradiated Plasmodium falciparum sporozoites. J Infect Dis 1993; 168 : 1066-70.
12. Cohen S, McGregor IA, Carrington S. Gamma-globulin and acquired immunity to human malaria. Nature 1961; 192 : 733-7.
13. McGregor A, Carrington SP. Treatment of East African P. falciparum malaria with West African human gamma-globulin. Trans R Soc Trop Med Hyg 1963; 57 : 170-5.
14. Sabchareon A, Burnouf T, Ouattara D, Attanath P. Bouharoun-Tayoun H, Chantavanich P et al. Parasitological and clinical human response to immunoglobulin administration in falciparum malaria. Am J Trop Med Hyg 1991; 45 : 297-308.
15. Hoffman SL, Sacci Jr. JB. Rationale and approaches to constructing preerythrocytic malaria vaccines. In : Powell MF, Newman MJ, editors Vaccine design: the subunit and adjuvant approach, New York: Plenum Press. 1995 : 787-802.
16. Wolff JA, Ludtke JJ, Acsadi G, Williams P, Jani A. Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle. Hum Mol Genet 1992; 1 : 363-9.
17. Doolan DL, Hoffman SL. Multi-gene vaccination against malaria: a multi-stage, multi-immune response approach. Parasitol Today 1997; 13 : 171-8.
18. Whalen RG. DNA vaccines. Cyberspace and self-help programs. URL: http:www.genweb.com/Dnavax/dnavax.html. Intervirology 1996; 39 : 120-5
19. Wolff JA, Malone RW, Williams P, Chong W, Acsadi G. Jani A et al. Direct gene transfer into mouse muscle in vivo. Science 1990; 247: 1465-8.
20. Ulmer JB, Donnelly JJ, Parker SE, Rhodes GH, Felgner PL, Dwarki VJ, et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 1993; 259: 1745-9.
21. Wang B, Ugen KE, Srikantan V, Agadjanyan MG. Dang K, Refaeli Y et al. Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc Natl Acad Sci USA 1993; 90 : 4156-60.
22. Raz E, Carson DA, Parker SE, Parr TB, Abai AM, Aichinger G et al. Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses. Proc Natl Acad Sci USA 1994; 91 : 9519-23.
23. Williams RS, Johnston SA, Riedy M, DeVit MJ, McElligott SG, Sanford JC. Introduction of foreign genes into tissues of living mice by DMA-coated microprojectiles. Proc Natl Acad Sci USA 1991; 88 : 2726-30.
24. Tang DC, DeVit M, Johnston, SA. Genetic immunization is a simple method for eliciting an immune response. Nature 1992; 356: 152-4.
25. Stoute JA, Slaoui M, Heppner DG, Monin P, Kester K, Desmons P et al. A preliminary evaluation of a recombinant ciircumsporozoite protein vaccine against Plasmodium falciparum malaria N Engl J Med 1997; 336 : 86-91.
26. Weiss WR, Berzofsky JA, Houghten RA. Sedegah M, Hollingdale M, Hoffman SL. A T cell clone directed at the circumsporozoite protein which protects mice against both Plasmodium yoelii and Plasmodium berghei. J Immunol 1992; 149: 2103-9.
27. Romero P, Maryanski JL, Corradin G, Nussenzweig RS, Nussenzweig V, Zavala F. Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria. Nature 1989; 341 : 323-5.
28. + cytolytic T cell clones derived against the Plasmodium yoelii circumsporozoite protein protect against malaria. Int Immunol 1991; 3 : 579-85.
29. Sadoff JC, Ballou WR, Baron LS, Majarian WR, Brey RN, Hockmeyer WT et al. Oral Salmonella typhimurium vaccine expressing circumsporozoite protein protects against malaria. Science 1988; 240 : 336-8.
30. + cytotoxic T cells. J Exp Med 1990; 172 : 1083-90.
31. Lanar DE, Tine JA, de Taisne C, Seguin MC, Cox WI, Winslow JP et al. Attenuated vaccinia virus circumsporozoite protein recombinants confer protection against rodent malaria. Infect Immun 1996; 64 : 1666-71.
32. Satchidanandam V, Zavala F, Moss B. Studies using a recombinant vaccinia virus expressing the circumsporozoite protein of Plasmodium berghei. Mol Biochem Parasitol 1991; 48 : 89-99.
33. Sedegah M, Beaudoin R L, De la Vega P, Leef MF, Ozcel MA, Jones E et al. Use of a vaccinia construct expressing the circumsporozoite protein in the analysis of protective immunity to Plasmodium yoelii. In : Lasky L, editor. Technological advances in vaccine development. New York: Liss 1988 : 295-309.
34. Flynn JL, Weiss WR, Norris KA, Seifert HS, Kumar S, So M. Generation of a cytotoxic T-lymphocyte response using a Salmonella antigen-delivery system. Mol Microbiol 1990; 4 : 2111-8.
35. Sedegah M, Beaudoin RL, Majarian WR, Cochran MD, Chiang CH, Sadoff J et al. Evaluation of vaccines designed to induce protective cellular immunity against the Plasmodium yoelii circumsporozoite protein: vaccinia. pseudorabies. and salmonella transformed with circumsporozoite gene. Bull WHO 68 Suppl., 1990 : 109-14.
36. Sedegah M, Chiang CH, Weiss WR, Mellouk S, Cochran MD, Houghton RA et al. Recombinant pseudorabies virus carrying a plasmodium gene: herpesvirus as a new live viral vector for inducing T- and B-cell immunity. Vaccine 1992; 10 : 578-84.
37. Khusmith S, Charoenvit Y, Kumar S, Sedegah M, Beaudoin RL, Hoffman SL Protection against malaria by vaccination with sporozoite surface protein 2 plus CS protein. Science 1991; 252: 715-8.
38. + T-cell-mediated protective immunity against malaria. Proc Natl Acad Sci USA 1993; 90 : 5214-8.
39. + T and B cell epitopes. Comparison of their immunogenicity and capacity to induce protective immunity. J Immunol 1994; 153, 4636-48.
40. Hoffman SL. Malaria Vaccine Development. In : Hoffman SL, editors. Malaria vaccine development, Washington D.C: ASM Press, 1996: 1-227.
41. Hoffman SL, Franke ED, Hollingdale MR, Druilhe P. Attacking the infected hepatocyte. In : Hoffman SL, editor. Malaria vaccine development, Washington DC: ASM Press, 1996 : 35-76.
42. + T cells and antibodies required for immunity to malaria sporozoites. Nature 1987; 330 : 664-6.
43. + T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites. Proc Natl Acad Sci USA 1988; 85 : 573-6.
44. + cytotoxic T cell clone recognizing sporozoite surface protein 2. Infect Immun 1994; 62 : 2979-83.
45. Weiss WR, Mellouk S, Houghten RA, Sedegah M, Kumar S, Good MF et al. Cytotoxic T cells recognize a peptide from the circumsporozoite protein on malaria-infected hepatocytes. J Exp Med 1990; 171 : 763-73.
46. Hoffman SL, Isenbarger D, Long G W, Sedegah M, Szarfman A, Waters L et al. Sporozoite vaccine induces genetically restricted T cell elimination of malaria from hepatocytes. Science 1989; 244 : 1078-81.
47. Hoffman SL, Isenbarger D, Long GW, Sedegah M, Szarfman A, Mellouk S et al. T lymphocytes from mice immunized with irradiated sporozoites eliminate malaria from hepatocytes. Bull WHO 1990; 68 suppl : 132-7.
48. Hoffman SL, Weiss W. Mellouk S, Sedegah M. irradiated sporozoite vaccine induces cytotoxic T lymphocytes that recognize malaria antigens on the surface of infected hepatocytes. Immunol Lett 1990; 25 : 33-8.
49. Lal AA, De La Cruz VF, Welsh JA, Charoenvit Y, Maloy WL, McCutchan TF Structure of the gene encoding the circumsporozoite protein of Plasmodium yoelii. A rodent model for examing antimalarial sporozoite vaccines. J Biol Chem 1987; 262: 2937-40.
50. Charoenvit Y, Mellouk S, Sedegah M, Toyoshima T, Leef MF, de la Vega P et al. 17 kDa Plasmodium yoelii hepatic and erythrocytic stage protein is the target of protective antibodies. Exp Parasitol 1995; 80 : 419-29.
51. Doolan DL, Hedstrom RC, Rogers WO, Charoenvit Y, Rogers M, de la Vega P et al. Characterization of the protective hepatocyte erythrocyte protein 17 kDa gene of Plasmodium yoelii: homolog of P. falciparum exported protein-1. J Biol Chem 1966; 271 : 17861-8.
52. Hedstrom RC, Campbell JR, Leef ML, Charoenvit Y, Carter M, Sedegah M et al. A malaria sporozoite surface antigen distinct from the circumsporozoite protein. Bull WHO 1990; 68 suppl: 152-7.
53. Rogers WO, Rogers MD, Hedstrom RC, Hoffman, SL. Characterization of the gene encoding sporozoite surface protein 2, a protective Plasmodium yoelii sporozoite antigen. Mol Biochem Parasitol 1992; 53 : 45-52.
54. Charoenvit Y, Leef MF, Yuan LF, Sedegah M., Beaudoin RL. Characterization of Plasmodium yoelii monoclonal antibodies directed against stage-specific sporozoite antigens. Infect Immun 1987; 55: 604-8.
55. Cullen BR. Trans-activation of human immunodeficiency virus occurs via a bimodal mechanism. Cell 1986; 46: 973-82.
56. Sedegah M. Hedstrom R, Hobart P. Hoffman SL. Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein. Proc Natl Acad Sci USA 1994; 91 : 9866-70.
57. Chapman BS, Thayer RM, Vincent KA, Haigwood NL. Effect of intron A from human cytomegalovirus (Towne) immediate-early gene on heterologous expression in mammalian cells. Nucleic Acids Res 1991; 19 : 3979-86.
58. + T cell, interferon-γ, and nitric oxide dependent immunity. J Exp Med 1966; 183 : 1739-46.
59. Yoshida N, Potocnjak P, Nussenzweig V, Nussenzweig RS. Biosynthesis of Pb44, the protective antigen of sporozoites of Plasmodium berghei. J Exp Med 1981; 154 : 1225-36.
60. Charoenvit Y, Mellouk S, Cole C, Bechara R, Leef MF, Sedegah M et al. Monoclonal, but not polyclonal antibodies protect against Plasmodium yoelli sporozoites. J Immunol 1991; 146: 1020-5.
61. Wang R. Charoenvit Y, Corradin G, Porrozzi R, Hunter RL, Glenn G et al. Induction of protective polyclonal antibodies by immunization with a Plasmodium yoelii circumsporozoite protein multiple antigen peptide vaccine. J Immunol 1995; 154 : 2784-93.
62. + T cells. J Exp Med 1994; 180, 353-8.
63. Campbell J R. DNA sequence of the gene encoding a Plasmodium falciparum malaria candidate vaccine antigen. Nucleic Acids Res 1989; 17 : 5854.
64. Sanchez GI, Rogers WO, Mellouk S. Hoffamn SL. Plasmodium falciparum: Exported protein-1, a blood stage antigen, is expressed in liver-stage parasites. Exp Parasitol 1994; 79 : 59-62.
65. Rogers WO, Malik A, Mellouk S, Nakamura K., Rogers MD. Szarfman A et al. Characterization of Plasmodium falciparum sporozoite surface protein 2. Proc Natl Acad Sci USA 1992; 89, 9176-80.
66. Zhu J, Hollingdale MR. Structure of Plasmodium falciparum liver stage antigen-1. Mol Biochem Parasitol 1991; 48 : 223-6.
67. Malik A, Egan JE, Houghton RA, Sadoff JC, the Hoffman SL. Human cytotoxic T lymphocytes against Plasmodium falciparum circumsporozoite protein. Proc Natl Acad Sci USA 1991; 88 : 3300-4.
68. Wizel B, Houghten R, Church P, Tine JA, Lunar DE, Gordon DM et al. HLA-A2 restricted cytotoxic T lymphocyte responses to multiple Plasmodium falciparum sporozoite protein 2 epitopes in sporozoite-immunized volunteers. J Immunol 1995; 155 : 766-75.
69. Wizel B, Houghten RA, Parker KC, Coligan JE, Church P, Gordon DM et al. Irradiated sporozoite vaccine induces HLA-B8-restricted cytotoxic T lymphocyte responses against two overlapping epitopes of the Plasmodium falciparum sporozoite surface protein 2. J Exp Med 1995; 182 : 1435-45.
70. Doolan DL, Hoffman SL, Southwood S, Wentworth PA, Sidney J, Chesnut RW et al. Degenerate cytotoxic T cell epitopes from P. falciparum restricted by multiple HLA-A and HLA-B supertype alleles. Immunity 1997; 7 : 1-16.
71. Doolan DL, Houghten RA, Good MF. Location of human cytotoxic T cell epitopes within a polymorphic domain of the Plasmodium falciparum circumsporozoite protein. Int Immunol 1991; 3: 511-6.
72. Hill AVS, Elvin J, Willis AC, Aidoo M, Allsopp CE, Gotch FM, et al. Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature 1992; 360 : 434-9.
73. + cytotoxic T lymphocytes against the Plasmodium falciparum circumsporozoite protein. J Immunol 1992; 149 : 966-71.
74. Aidoo M, Lalvani A, Allsopp CEM, Plebanski M, Meisner SJ, Krausa P, et al. Identification of conserved antigenic components for a cytotoxic T lymphocyte-inducing vaccine against malaria. Lancet 1995; 345 : 1003-7.
75. Lalvani A, Hurt N, Aidoo M, Kibatala P, Tanner M, Hill AVS, Cytotoxic T lymphocytes to Plasmodium falciparum epitopes in an area of intense and perennial transmission in Tanzania. Eur J Immunol 1996; 26 : 773-779.
76. Hartikka J, Sawdey M, Cornefert-Jensen F, Margalith M. Barnhart K, Vahlsing L et al. An improved plasmid DNA expression vector for direct injection into skeletal muscle. Human Gene Therapy 1996; 7 : 1205-17.
77. Luke CJ, Garner K, Liang X, Barbour AG. An OspA-based DNA vaccine protects mice against infection with Borrelai burgdorferi. J Infect Dis 1977; 175 : 91-7.